Pharmacogenetics Testing in Psychiatry/Depression Market: Precision Mental Health — The Genetic Edge in Depression Treatment
" According to the latest report published by Data Bridge Market Research, the Pharmacogenetics Testing in Psychiatry/Depression Market  CAGR Value The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period Pharmacogenetics...
0 Commenti 0 condivisioni 74 Views 0 Anteprima